During the past decade, Teine Keijinkai Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Teine Keijinkai Hospital" #1 sponsor was "Bayer" with 4 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Teine Keijinkai Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Guidant Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Teine Keijinkai Hospital" are "Anemia" (2 trials), "Heart Failure" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Arrhythmias, Cardiac" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Teine Keijinkai Hospital" in a lesser frequency.

Most popular intervention types in "Teine Keijinkai Hospital" are "Drug" (7 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "Placebo" (2 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Teine Keijinkai Hospital" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Teine Keijinkai Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Teine Keijinkai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Teine Keijinkai Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".